The striking dichotomy of actions on tumor cells of the endogenous thyroid hormone analogue inventory consisting of T4/tetrac/T3 may be driven by the distinct affinities toward intracellular/nuclear (T3 >> T4 > tetrac) versus extracellular/cell membrane (tetrac > T4 >> T3) receptors [4]. The gene discussed is TG; the disease is neoplasm.